Risks for Hospitalization and Death Among Patients with Blood Disorders from the ASH RC COVID-19 Registry for Hematology
Hicks L, Redd R, Anderson K, Desai P, Dolan B, Goldberg A, Narendra V, Neuberg D, Radhakrishnan V, Sehn L, Sekeres M, Stahl M, Tallman M, Thompson J, Tucker E, Wood W. Risks for Hospitalization and Death Among Patients with Blood Disorders from the ASH RC COVID-19 Registry for Hematology. Blood 2021, 138: 3040. PMCID: PMC8701544, DOI: 10.1182/blood-2021-154283.Peer-Reviewed Original ResearchEntity's Board of DirectorsTypes of hematological malignanciesPlasma cell dyscrasiaHematologic malignanciesCOVID-19 mortalityMultivariate logistic regressionGrand roundsCOVID-19 registryMale sexCancer treatmentIncreased riskMultivariate analysisICU carePre-COVID-19Blood disordersBristol Myers SquibbCOVID-19 infectionImpact of cancer treatmentLogistic regressionAdvisory CommitteeResearch fundingRisk of COVID-19 mortalityIncreased risk of COVID-19 mortalityMedian age categoryOutcomes of COVID-19 infection
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply